SAB Biotherapeutics Sets Third-Quarter Results Conference Call

• SAB Biotherapeutics will release third-quarter 2026 financial results on the morning of Nov. 5, 2026.
• Management will host a conference call and webcast on Nov. 5 at 8:30 a.m. ET to discuss results and business updates.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SAB Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290830PRIMZONEFULLFEED9851620) on October 29, 2026, and is solely responsible for the information contained therein.